Tg Therapeutics (TGTX) Net Margin Growth (1y) (2018 - 2026)
Tg Therapeutics (TGTX) Net Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,491.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 680.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Tg Therapeutics | 8.08 Bn | 8.00 Bn | 171.41 Mn | 545.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 545.00 |
| Dec 31, 2025 | -1,685.00 |
| Sep 30, 2025 | 23,712.00 |
| Jun 30, 2025 | 1,064.00 |
| Mar 31, 2025 | 2,106.00 |
| Dec 31, 2024 | 5,932.00 |
| Sep 30, 2024 | -6,410.00 |
| Jun 30, 2024 | 30,552.00 |
| Mar 31, 2024 | 48,591.00 |
| Dec 31, 2023 | 10.47 Mn |
| Sep 30, 2023 | 4.36 Mn |
| Jun 30, 2023 | 917,014.00 |
| Mar 31, 2023 | 322,405.00 |
| Dec 31, 2022 | -10.06 Mn |
| Sep 30, 2022 | -3.85 Mn |
| Jun 30, 2022 | -400,698.00 |
| Mar 31, 2022 | 787,493.00 |
| Dec 31, 2021 | 22.70 Mn |
| Sep 30, 2021 | 13.38 Bn |
| Jun 30, 2021 | 8.93 Bn |